Health News

A simple brain-training program that sharpens how quickly older adults process visual information may have a surprisingly powerful long-term payoff. In a major 20-year study of adults 65 and older, those who completed five to six weeks of adaptive “speed of processing” training — along with a few booster sessions — were significantly less likely to develop dementia, including Alzheimer’s disease, even two decades later. Participants who received the boosted speed training had a 25% lower dementia risk compared to those who received no training, making it the only intervention in the trial to show such a lasting protective effect.

A new clinical trial suggests that changing when you eat could make a meaningful difference for people living with Crohn’s disease. Researchers found that time-restricted feeding, a form of intermittent fasting that limits meals to an 8-hour daily window, reduced disease activity by 40% and cut abdominal discomfort in half over 12 weeks. Participants also lost weight and showed healthier inflammation and immune markers, even though they did not reduce calories or change what they ate.

Three major reviews commissioned by the World Health Organization find that GLP-1 drugs including tirzepatide (sold as Mounjaro and Zepbound), semaglutide (Ozempic and Wegovy), and liraglutide (Victoza and Saxenda) can lead to substantial weight loss in people with obesity. But while the results are impressive, researchers caution that most trials were funded by drugmakers, long term safety data are still limited, and side effects such as nausea are common.

Depression in older adults may sometimes signal the early stages of Parkinson’s disease or Lewy body dementia. Researchers found that depression often appears years before diagnosis and remains elevated long afterward, unlike in other chronic illnesses. This suggests depression may reflect early brain changes rather than emotional distress alone.

A cooler bedroom might be better for older sleepers than previously thought. Researchers found that keeping nighttime temperatures at 75°F reduced stress responses and helped the heart work more efficiently during sleep. Hot nights usually force the heart to work harder, interfering with recovery. As climate change drives warmer nights, this small adjustment could make a big difference.

Blood vessels twist, branch, narrow, and balloon in ways that dramatically affect how blood flows — but most lab models have long treated them like straight pipes. Researchers at Texas A&M have now built a new kind of “vessel-chip” that mirrors the real complexity of human blood vessels, from aneurysms to dangerous constrictions.

Why does the same virus barely faze one person while sending another to the hospital? New research shows the answer lies in a molecular record etched into our immune cells by both our genes and our life experiences. Scientists at the Salk Institute have created a detailed epigenetic map of human immune cells, revealing how inherited traits and past exposures—like infections, vaccines, or even environmental chemicals—shape immune responses in different ways.

A bonobo named Kanzi surprised scientists by successfully playing along in pretend tea party experiments, tracking imaginary juice and grapes as if they were real. He consistently pointed to the correct locations of pretend items, while still choosing real food when given the option. The results suggest that imagination may not be exclusive to humans after all.

Ultra-processed foods are everywhere in the American diet, and researchers are finding alarming consequences. Using national health data, scientists found that adults with the highest intake of these foods had a 47% higher risk of heart attack or stroke. The results held even after accounting for age, smoking, and income. Experts say reducing ultra-processed foods could become as important to public health as cutting back on tobacco once was.

Scientists have uncovered a surprising way tumors turn the immune system to their advantage. Researchers at the University of Geneva found that neutrophils—normally frontline defenders against infection—can be reprogrammed inside tumors to fuel cancer growth instead. Once exposed to the tumor environment, these immune cells begin producing a molecule called CCL3 that actively promotes tumor progression.